Experimental Gene Therapy for Type 1 Spinal Muscular Atrophy Gets Priority Review

According to a story from BioPortfolio, the drug developer Novartis recently announced that the US Food and Drug Administration (FDA) has granted the company's investigational gene therapy AVXS-101, also known…

Continue Reading Experimental Gene Therapy for Type 1 Spinal Muscular Atrophy Gets Priority Review
A Woman With Spinal Muscular Atrophy is Fighting for Access to the Therapy That Could Save Her
source: pixabay.com

A Woman With Spinal Muscular Atrophy is Fighting for Access to the Therapy That Could Save Her

According to a story from MarketWatch, Annie Wilson was diagnosed with spinal muscular atrophy when she was only six months old. With no real treatment options available, doctors told her…

Continue Reading A Woman With Spinal Muscular Atrophy is Fighting for Access to the Therapy That Could Save Her

Cure SMA’s Annual SMA Conference

  • Post author:
  • Post category:

The 2018 Annual SMA Conference This conference will bring together researchers, medical experts, scientists, and patient families to build community, learn, collaborate, and network. The conference consists of two parallel…

Continue Reading Cure SMA’s Annual SMA Conference
Spinraza, a New Drug For SMA Patients Might Be Available Sooner Than Later in the UK
Source: Pixabay

Spinraza, a New Drug For SMA Patients Might Be Available Sooner Than Later in the UK

There is new hope for patients and their families suffering from spinal muscular atrophy (SMA) reported AOL UK News. SMA is a physically debilitating and aggressive disease, and now a new…

Continue Reading Spinraza, a New Drug For SMA Patients Might Be Available Sooner Than Later in the UK